222 related articles for article (PubMed ID: 23363077)
1. Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A.
Zhang W; Sviripa V; Chen X; Shi J; Yu T; Hamza A; Ward ND; Kril LM; Vander Kooi CW; Zhan CG; Evers BM; Watt DS; Liu C
ACS Chem Biol; 2013 Apr; 8(4):796-803. PubMed ID: 23363077
[TBL] [Abstract][Full Text] [Related]
2. 2',6'-Dihalostyrylanilines, pyridines, and pyrimidines for the inhibition of the catalytic subunit of methionine S-adenosyltransferase-2.
Sviripa VM; Zhang W; Balia AG; Tsodikov OV; Nickell JR; Gizard F; Yu T; Lee EY; Dwoskin LP; Liu C; Watt DS
J Med Chem; 2014 Jul; 57(14):6083-91. PubMed ID: 24950374
[TBL] [Abstract][Full Text] [Related]
3. S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis.
Tomasi ML; Cossu C; Spissu Y; Floris A; Ryoo M; Iglesias-Ara A; Wang Q; Pandol SJ; Bhowmick NA; Seki E; Posadas EM; Lu SC
Oncotarget; 2017 Oct; 8(45):78851-78869. PubMed ID: 29108270
[TBL] [Abstract][Full Text] [Related]
4. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
6. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.
Tomasi ML; Ryoo M; Skay A; Tomasi I; Giordano P; Mato JM; Lu SC
Exp Cell Res; 2013 Jul; 319(12):1902-1911. PubMed ID: 23588207
[TBL] [Abstract][Full Text] [Related]
7. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
[TBL] [Abstract][Full Text] [Related]
8. mTORC1-independent translation control in mammalian cells by methionine adenosyltransferase 2A and S-adenosylmethionine.
Alam M; Shima H; Matsuo Y; Long NC; Matsumoto M; Ishii Y; Sato N; Sugiyama T; Nobuta R; Hashimoto S; Liu L; Kaneko MK; Kato Y; Inada T; Igarashi K
J Biol Chem; 2022 Jul; 298(7):102084. PubMed ID: 35636512
[TBL] [Abstract][Full Text] [Related]
9. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma.
Wang Y; Muylaert C; Wyns A; Vlummens P; De Veirman K; Vanderkerken K; Zaal E; Berkers C; Moreaux J; De Bruyne E; Menu E
Haematologica; 2024 Jan; 109(1):256-271. PubMed ID: 37470139
[TBL] [Abstract][Full Text] [Related]
10. Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors.
Li C; Gui G; Zhang L; Qin A; Zhou C; Zha X
J Med Chem; 2022 Jul; 65(14):9531-9547. PubMed ID: 35796517
[TBL] [Abstract][Full Text] [Related]
11. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics.
Nordgren KK; Peng Y; Pelleymounter LL; Moon I; Abo R; Feng Q; Eckloff B; Yee VC; Wieben E; Weinshilboum RM
Drug Metab Dispos; 2011 Nov; 39(11):2135-47. PubMed ID: 21813468
[TBL] [Abstract][Full Text] [Related]
12. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
Maldonado LY; Arsene D; Mato JM; Lu SC
Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
[TBL] [Abstract][Full Text] [Related]
13. Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B.
Bailey J; Douglas H; Masino L; de Carvalho LPS; Argyrou A
Biochemistry; 2021 Nov; 60(47):3621-3632. PubMed ID: 34780697
[TBL] [Abstract][Full Text] [Related]
14. Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy.
Guo J; Yang Y; Buettner R; Rosen ST
Curr Opin Oncol; 2022 Sep; 34(5):546-551. PubMed ID: 35788128
[TBL] [Abstract][Full Text] [Related]
15. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.
Strekalova E; Malin D; Weisenhorn EMM; Russell JD; Hoelper D; Jain A; Coon JJ; Lewis PW; Cryns VL
Breast Cancer Res Treat; 2019 May; 175(1):39-50. PubMed ID: 30712196
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 activates methionine adenosyltransferase 2A transcription by multiple pathways in human colon cancer cells.
Yang H; Li TW; Peng J; Mato JM; Lu SC
Biochem J; 2011 Jun; 436(2):507-16. PubMed ID: 21406062
[TBL] [Abstract][Full Text] [Related]
17. Insight into S-adenosylmethionine biosynthesis from the crystal structures of the human methionine adenosyltransferase catalytic and regulatory subunits.
Shafqat N; Muniz JR; Pilka ES; Papagrigoriou E; von Delft F; Oppermann U; Yue WW
Biochem J; 2013 May; 452(1):27-36. PubMed ID: 23425511
[TBL] [Abstract][Full Text] [Related]
18. Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.
Wang X; Guo X; Yu W; Li C; Gui Y; Cai Z
BMC Cancer; 2014 Mar; 14():196. PubMed ID: 24636201
[TBL] [Abstract][Full Text] [Related]
19. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
[TBL] [Abstract][Full Text] [Related]
20. The role of c-Myb in the up-regulation of methionine adenosyltransferase 2A expression in activated Jurkat cells.
Zeng Z; Yang H; Huang ZZ; Chen C; Wang J; Lu SC
Biochem J; 2001 Jan; 353(Pt 1):163-168. PubMed ID: 11115410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
